Peter Gray - Net Worth and Insider Trading

Peter Gray Net Worth

The estimated net worth of Peter Gray is at least $2 Million dollars as of 2024-11-13. Peter Gray is the Director of Jazz Pharmaceuticals PLC and owns about 16,068 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $2 Million. Details can be seen in Peter Gray's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Gray has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter Gray

To

Peter Gray Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Gray owns 1 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) .

Click here to see the complete history of Peter Gray’s form 4 insider trades.

Insider Ownership Summary of Peter Gray

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 director

Peter Gray Latest Holdings Summary

Peter Gray currently owns a total of 1 stock. Peter Gray owns 16,068 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 14, 2023, with a value of $2 Million.

Latest Holdings of Peter Gray

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 16,068 127.70 2,051,884

Holding Weightings of Peter Gray


Peter Gray Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Gray has made a total of 4 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,241 shares on August 14, 2023, which brought Peter Gray around $171,457.

Insider Trading History of Peter Gray

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Gray Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter Gray Ownership Network

Ownership Network List of Peter Gray

No Data

Ownership Network Relation of Peter Gray

Insider Network Chart

Peter Gray Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Peter Gray is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include director & Executive Chairman Bruce C Cozadd , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Peter Gray made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Peter Gray Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Gray. You might contact Peter Gray via mailing address: C/o Jazz Pharmaceuticals Plc, 5th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4 L2.